Expert BA/DMPK Services
Bioanalysis and DMPK expertise, from first dose to filing.
Ashland Research Technology Inc. (ARTI) helps drug developers design, run, and interpret bioanalytical and DMPK programs, and modernize the workflows behind them.
Plasma concentration–time profile
semi-log
- 30 years
- in bioanalysis and DMPK
- Discovery → Phase 4
- development coverage
- IND · NDA · ANDA
- submission support
- GLP · GMP · CLIA
- regulated environments
Explore ARTI
Decades of BA/DMPK leadership, now working for your program.
01
Services
Bioanalysis, nonclinical DMPK, PK/TK analysis, regulatory strategy, CRO oversight, and training.
02Track record
A dozen INDs, NDA approvals across five regions, and recognized workflow automation.
03Publications
Industry white papers, book chapters, invited talks, and conference sessions.
04About Dr. Ho
30 years across CDC, CROs, Sanofi/Genzyme, and Roche, now leading ARTI.